自己免疫・炎症性免疫調節剤の世界市場（～2026年）

• 英文タイトル：Global Autoimmune and Inflammatory Immunomodulators Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02744
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は自己免疫・炎症性免疫調節剤のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（関節リウマチ、IBD）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別自己免疫・炎症性免疫調節剤の競争状況、市場シェア
・世界の自己免疫・炎症性免疫調節剤市場：種類別市場規模 2015年-2020年（生物製剤、小分子）
・世界の自己免疫・炎症性免疫調節剤市場：種類別市場規模予測 2021年-2026年（生物製剤、小分子）
・世界の自己免疫・炎症性免疫調節剤市場：用途別市場規模 2015年-2020年（関節リウマチ、IBD）
・世界の自己免疫・炎症性免疫調節剤市場：用途別市場規模予測 2021年-2026年（関節リウマチ、IBD）
・北米の自己免疫・炎症性免疫調節剤市場分析：米国、カナダ
・ヨーロッパの自己免疫・炎症性免疫調節剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの自己免疫・炎症性免疫調節剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の自己免疫・炎症性免疫調節剤市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの自己免疫・炎症性免疫調節剤市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：AbbVie、Johnson & Johnson、Amgen、F. Hoffmann-La Roche、Pfizer、AstraZeneca、Avaxia Biologics、Biogen Idec、Bristol-Myers Squibb、Boehringer Ingelheim、Eli Lilly、Enlivex Therapeutics、Gilead Sciences
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Autoimmune and Inflammatory Immunomodulators Market
The global Autoimmune and Inflammatory Immunomodulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Autoimmune and Inflammatory Immunomodulators Scope and Market Size
Autoimmune and Inflammatory Immunomodulators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune and Inflammatory Immunomodulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Autoimmune and Inflammatory Immunomodulators market is segmented into
Biologics
Small molecules

Segment by Application, the Autoimmune and Inflammatory Immunomodulators market is segmented into
Rheumatoid arthritis
IBD

Regional and Country-level Analysis
The Autoimmune and Inflammatory Immunomodulators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Autoimmune and Inflammatory Immunomodulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Autoimmune and Inflammatory Immunomodulators Market Share Analysis
Autoimmune and Inflammatory Immunomodulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Autoimmune and Inflammatory Immunomodulators business, the date to enter into the Autoimmune and Inflammatory Immunomodulators market, Autoimmune and Inflammatory Immunomodulators product introduction, recent developments, etc.

The major vendors covered:
AbbVie
Johnson & Johnson
Amgen
F. Hoffmann-La Roche
Pfizer
AstraZeneca
Avaxia Biologics
Biogen Idec
Bristol-Myers Squibb
Boehringer Ingelheim
Eli Lilly
Enlivex Therapeutics
Gilead Sciences

レポート目次

1 Study Coverage
1.1 Autoimmune and Inflammatory Immunomodulators Product Introduction
1.2 Market Segments
1.3 Key Autoimmune and Inflammatory Immunomodulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Autoimmune and Inflammatory Immunomodulators Market Size Growth Rate by Type
1.4.2 Biologics
1.4.3 Small molecules
1.5 Market by Application
1.5.1 Global Autoimmune and Inflammatory Immunomodulators Market Size Growth Rate by Application
1.5.2 Rheumatoid arthritis
1.5.3 IBD
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Autoimmune and Inflammatory Immunomodulators Market Size, Estimates and Forecasts
2.1.1 Global Autoimmune and Inflammatory Immunomodulators Revenue 2015-2026
2.1.2 Global Autoimmune and Inflammatory Immunomodulators Sales 2015-2026
2.2 Global Autoimmune and Inflammatory Immunomodulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Autoimmune and Inflammatory Immunomodulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Autoimmune and Inflammatory Immunomodulators Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Autoimmune and Inflammatory Immunomodulators Competitor Landscape by Players
3.1 Autoimmune and Inflammatory Immunomodulators Sales by Manufacturers
3.1.1 Autoimmune and Inflammatory Immunomodulators Sales by Manufacturers (2015-2020)
3.1.2 Autoimmune and Inflammatory Immunomodulators Sales Market Share by Manufacturers (2015-2020)
3.2 Autoimmune and Inflammatory Immunomodulators Revenue by Manufacturers
3.2.1 Autoimmune and Inflammatory Immunomodulators Revenue by Manufacturers (2015-2020)
3.2.2 Autoimmune and Inflammatory Immunomodulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Autoimmune and Inflammatory Immunomodulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Autoimmune and Inflammatory Immunomodulators Revenue in 2019
3.2.5 Global Autoimmune and Inflammatory Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Autoimmune and Inflammatory Immunomodulators Price by Manufacturers
3.4 Autoimmune and Inflammatory Immunomodulators Manufacturing Base Distribution, Product Types
3.4.1 Autoimmune and Inflammatory Immunomodulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Autoimmune and Inflammatory Immunomodulators Product Type
3.4.3 Date of International Manufacturers Enter into Autoimmune and Inflammatory Immunomodulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Autoimmune and Inflammatory Immunomodulators Market Size by Type (2015-2020)
4.1.1 Global Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020)
4.1.2 Global Autoimmune and Inflammatory Immunomodulators Revenue by Type (2015-2020)
4.1.3 Autoimmune and Inflammatory Immunomodulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Type (2021-2026)
4.2.2 Global Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Type (2021-2026)
4.2.3 Autoimmune and Inflammatory Immunomodulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Autoimmune and Inflammatory Immunomodulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Autoimmune and Inflammatory Immunomodulators Market Size by Application (2015-2020)
5.1.1 Global Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020)
5.1.2 Global Autoimmune and Inflammatory Immunomodulators Revenue by Application (2015-2020)
5.1.3 Autoimmune and Inflammatory Immunomodulators Price by Application (2015-2020)
5.2 Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Application (2021-2026)
5.2.2 Global Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Autoimmune and Inflammatory Immunomodulators Price Forecast by Application (2021-2026)

6 North America
6.1 North America Autoimmune and Inflammatory Immunomodulators by Country
6.1.1 North America Autoimmune and Inflammatory Immunomodulators Sales by Country
6.1.2 North America Autoimmune and Inflammatory Immunomodulators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Type
6.3 North America Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Application

7 Europe
7.1 Europe Autoimmune and Inflammatory Immunomodulators by Country
7.1.1 Europe Autoimmune and Inflammatory Immunomodulators Sales by Country
7.1.2 Europe Autoimmune and Inflammatory Immunomodulators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Type
7.3 Europe Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Autoimmune and Inflammatory Immunomodulators by Region
8.1.1 Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Region
8.1.2 Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Type
8.3 Asia Pacific Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Application

9 Latin America
9.1 Latin America Autoimmune and Inflammatory Immunomodulators by Country
9.1.1 Latin America Autoimmune and Inflammatory Immunomodulators Sales by Country
9.1.2 Latin America Autoimmune and Inflammatory Immunomodulators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Type
9.3 Central & South America Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Autoimmune and Inflammatory Immunomodulators by Country
10.1.1 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Country
10.1.2 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Type
10.3 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Autoimmune and Inflammatory Immunomodulators Products Offered
11.1.5 AbbVie Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description and Business Overview
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Products Offered
11.2.5 Johnson & Johnson Related Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description and Business Overview
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Autoimmune and Inflammatory Immunomodulators Products Offered
11.3.5 Amgen Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Autoimmune and Inflammatory Immunomodulators Products Offered
11.5.5 Pfizer Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Autoimmune and Inflammatory Immunomodulators Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Avaxia Biologics
11.7.1 Avaxia Biologics Corporation Information
11.7.2 Avaxia Biologics Description and Business Overview
11.7.3 Avaxia Biologics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Products Offered
11.7.5 Avaxia Biologics Related Developments
11.8 Biogen Idec
11.8.1 Biogen Idec Corporation Information
11.8.2 Biogen Idec Description and Business Overview
11.8.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biogen Idec Autoimmune and Inflammatory Immunomodulators Products Offered
11.8.5 Biogen Idec Related Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Corporation Information
11.9.2 Bristol-Myers Squibb Description and Business Overview
11.9.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Products Offered
11.9.5 Bristol-Myers Squibb Related Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Corporation Information
11.10.2 Boehringer Ingelheim Description and Business Overview
11.10.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Products Offered
11.10.5 Boehringer Ingelheim Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Autoimmune and Inflammatory Immunomodulators Products Offered
11.1.5 AbbVie Related Developments
11.12 Enlivex Therapeutics
11.12.1 Enlivex Therapeutics Corporation Information
11.12.2 Enlivex Therapeutics Description and Business Overview
11.12.3 Enlivex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Enlivex Therapeutics Products Offered
11.12.5 Enlivex Therapeutics Related Developments
11.13 Gilead Sciences
11.13.1 Gilead Sciences Corporation Information
11.13.2 Gilead Sciences Description and Business Overview
11.13.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Gilead Sciences Products Offered
11.13.5 Gilead Sciences Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Autoimmune and Inflammatory Immunomodulators Market Estimates and Projections by Region
12.1.1 Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Regions 2021-2026
12.1.2 Global Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Regions 2021-2026
12.2 North America Autoimmune and Inflammatory Immunomodulators Market Size Forecast (2021-2026)
12.2.1 North America: Autoimmune and Inflammatory Immunomodulators Sales Forecast (2021-2026)
12.2.2 North America: Autoimmune and Inflammatory Immunomodulators Revenue Forecast (2021-2026)
12.2.3 North America: Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Country (2021-2026)
12.3 Europe Autoimmune and Inflammatory Immunomodulators Market Size Forecast (2021-2026)
12.3.1 Europe: Autoimmune and Inflammatory Immunomodulators Sales Forecast (2021-2026)
12.3.2 Europe: Autoimmune and Inflammatory Immunomodulators Revenue Forecast (2021-2026)
12.3.3 Europe: Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Autoimmune and Inflammatory Immunomodulators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Autoimmune and Inflammatory Immunomodulators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Autoimmune and Inflammatory Immunomodulators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Region (2021-2026)
12.5 Latin America Autoimmune and Inflammatory Immunomodulators Market Size Forecast (2021-2026)
12.5.1 Latin America: Autoimmune and Inflammatory Immunomodulators Sales Forecast (2021-2026)
12.5.2 Latin America: Autoimmune and Inflammatory Immunomodulators Revenue Forecast (2021-2026)
12.5.3 Latin America: Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Autoimmune and Inflammatory Immunomodulators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Autoimmune and Inflammatory Immunomodulators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Autoimmune and Inflammatory Immunomodulators Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Autoimmune and Inflammatory Immunomodulators Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Autoimmune and Inflammatory Immunomodulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Autoimmune and Inflammatory Immunomodulators Market Segments
Table 2. Ranking of Global Top Autoimmune and Inflammatory Immunomodulators Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Autoimmune and Inflammatory Immunomodulators Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Biologics
Table 5. Major Manufacturers of Small molecules
Table 6. Global Autoimmune and Inflammatory Immunomodulators Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Autoimmune and Inflammatory Immunomodulators Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Autoimmune and Inflammatory Immunomodulators Sales by Regions 2015-2020 (K Units)
Table 9. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Regions (2015-2020)
Table 10. Global Autoimmune and Inflammatory Immunomodulators Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Autoimmune and Inflammatory Immunomodulators Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Manufacturers (2015-2020)
Table 13. Global Autoimmune and Inflammatory Immunomodulators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Autoimmune and Inflammatory Immunomodulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune and Inflammatory Immunomodulators as of 2019)
Table 15. Autoimmune and Inflammatory Immunomodulators Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Autoimmune and Inflammatory Immunomodulators Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Autoimmune and Inflammatory Immunomodulators Price (2015-2020) (USD/Unit)
Table 18. Autoimmune and Inflammatory Immunomodulators Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Autoimmune and Inflammatory Immunomodulators Product Type
Table 20. Date of International Manufacturers Enter into Autoimmune and Inflammatory Immunomodulators Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 23. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Type (2015-2020)
Table 24. Global Autoimmune and Inflammatory Immunomodulators Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Autoimmune and Inflammatory Immunomodulators Revenue Share by Type (2015-2020)
Table 26. Autoimmune and Inflammatory Immunomodulators Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 28. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Application (2015-2020)
Table 29. North America Autoimmune and Inflammatory Immunomodulators Sales by Country (2015-2020) (K Units)
Table 30. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2015-2020)
Table 31. North America Autoimmune and Inflammatory Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2015-2020)
Table 33. North America Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 34. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Table 35. North America Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 36. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Table 37. Europe Autoimmune and Inflammatory Immunomodulators Sales by Country (2015-2020) (K Units)
Table 38. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2015-2020)
Table 39. Europe Autoimmune and Inflammatory Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2015-2020)
Table 41. Europe Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 42. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Table 43. Europe Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 44. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Table 53. Latin America Autoimmune and Inflammatory Immunomodulators Sales by Country (2015-2020) (K Units)
Table 54. Latin America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Autoimmune and Inflammatory Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2015-2020)
Table 57. Latin America Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 58. Latin America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Table 59. Latin America Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 60. Latin America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Table 69. AbbVie Corporation Information
Table 70. AbbVie Description and Major Businesses
Table 71. AbbVie Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. AbbVie Product
Table 73. AbbVie Recent Development
Table 74. Johnson & Johnson Corporation Information
Table 75. Johnson & Johnson Description and Major Businesses
Table 76. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Johnson & Johnson Product
Table 78. Johnson & Johnson Recent Development
Table 79. Amgen Corporation Information
Table 80. Amgen Description and Major Businesses
Table 81. Amgen Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Amgen Product
Table 83. Amgen Recent Development
Table 84. F. Hoffmann-La Roche Corporation Information
Table 85. F. Hoffmann-La Roche Description and Major Businesses
Table 86. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. F. Hoffmann-La Roche Product
Table 88. F. Hoffmann-La Roche Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. AstraZeneca Corporation Information
Table 95. AstraZeneca Description and Major Businesses
Table 96. AstraZeneca Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. AstraZeneca Product
Table 98. AstraZeneca Recent Development
Table 99. Avaxia Biologics Corporation Information
Table 100. Avaxia Biologics Description and Major Businesses
Table 101. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Avaxia Biologics Product
Table 103. Avaxia Biologics Recent Development
Table 104. Biogen Idec Corporation Information
Table 105. Biogen Idec Description and Major Businesses
Table 106. Biogen Idec Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Biogen Idec Product
Table 108. Biogen Idec Recent Development
Table 109. Bristol-Myers Squibb Corporation Information
Table 110. Bristol-Myers Squibb Description and Major Businesses
Table 111. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Recent Development
Table 114. Boehringer Ingelheim Corporation Information
Table 115. Boehringer Ingelheim Description and Major Businesses
Table 116. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Boehringer Ingelheim Product
Table 118. Boehringer Ingelheim Recent Development
Table 119. Eli Lilly Corporation Information
Table 120. Eli Lilly Description and Major Businesses
Table 121. Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Eli Lilly Product
Table 123. Eli Lilly Recent Development
Table 124. Enlivex Therapeutics Corporation Information
Table 125. Enlivex Therapeutics Description and Major Businesses
Table 126. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Enlivex Therapeutics Product
Table 128. Enlivex Therapeutics Recent Development
Table 129. Gilead Sciences Corporation Information
Table 130. Gilead Sciences Description and Major Businesses
Table 131. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Gilead Sciences Product
Table 133. Gilead Sciences Recent Development
Table 134. Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Regions (2021-2026) (K Units)
Table 135. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Autoimmune and Inflammatory Immunomodulators Sales Forecast by Country (2021-2026) (K Units)
Table 139. North America: Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Autoimmune and Inflammatory Immunomodulators Sales Forecast by Country (2021-2026) (K Units)
Table 141. Europe: Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Autoimmune and Inflammatory Immunomodulators Sales Forecast by Region (2021-2026) (K Units)
Table 143. Asia Pacific: Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Autoimmune and Inflammatory Immunomodulators Sales Forecast by Country (2021-2026) (K Units)
Table 145. Latin America: Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Autoimmune and Inflammatory Immunomodulators Sales Forecast by Country (2021-2026) (K Units)
Table 147. Middle East and Africa: Autoimmune and Inflammatory Immunomodulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Autoimmune and Inflammatory Immunomodulators Players
Table 152. Autoimmune and Inflammatory Immunomodulators Customers List
Table 153. Autoimmune and Inflammatory Immunomodulators Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Autoimmune and Inflammatory Immunomodulators Product Picture
Figure 2. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type in 2020 & 2026
Figure 3. Biologics Product Picture
Figure 4. Small molecules Product Picture
Figure 5. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application in 2020 & 2026
Figure 6. Rheumatoid arthritis
Figure 7. IBD
Figure 8. Autoimmune and Inflammatory Immunomodulators Report Years Considered
Figure 9. Global Autoimmune and Inflammatory Immunomodulators Market Size 2015-2026 (US$ Million)
Figure 10. Global Autoimmune and Inflammatory Immunomodulators Sales 2015-2026 (K Units)
Figure 11. Global Autoimmune and Inflammatory Immunomodulators Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region (2015-2020)
Figure 13. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region in 2019
Figure 14. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region (2015-2020)
Figure 15. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region in 2019
Figure 16. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Autoimmune and Inflammatory Immunomodulators Revenue in 2019
Figure 18. Autoimmune and Inflammatory Immunomodulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type (2015-2020)
Figure 20. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Type in 2019
Figure 21. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Type (2015-2020)
Figure 22. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Type in 2019
Figure 23. Global Autoimmune and Inflammatory Immunomodulators Market Share by Price Range (2015-2020)
Figure 24. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
Figure 25. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application in 2019
Figure 26. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Application (2015-2020)
Figure 27. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Application in 2019
Figure 28. North America Autoimmune and Inflammatory Immunomodulators Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country in 2019
Figure 31. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country in 2019
Figure 32. U.S. Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Autoimmune and Inflammatory Immunomodulators Market Share by Type in 2019
Figure 37. North America Autoimmune and Inflammatory Immunomodulators Market Share by Application in 2019
Figure 38. Europe Autoimmune and Inflammatory Immunomodulators Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country in 2019
Figure 41. Europe Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country in 2019
Figure 42. Germany Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Autoimmune and Inflammatory Immunomodulators Market Share by Type in 2019
Figure 53. Europe Autoimmune and Inflammatory Immunomodulators Market Share by Application in 2019
Figure 54. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Region in 2019
Figure 57. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Region in 2019
Figure 58. China Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Autoimmune and Inflammatory Immunomodulators Market Share by Type in 2019
Figure 81. Asia Pacific Autoimmune and Inflammatory Immunomodulators Market Share by Application in 2019
Figure 82. Latin America Autoimmune and Inflammatory Immunomodulators Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country in 2019
Figure 85. Latin America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country in 2019
Figure 86. Mexico Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Autoimmune and Inflammatory Immunomodulators Market Share by Type in 2019
Figure 93. Latin America Autoimmune and Inflammatory Immunomodulators Market Share by Application in 2019
Figure 94. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Country in 2019
Figure 98. Turkey Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Autoimmune and Inflammatory Immunomodulators Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Market Share by Type in 2019
Figure 105. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Market Share by Application in 2019
Figure 106. North America Autoimmune and Inflammatory Immunomodulators Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Autoimmune and Inflammatory Immunomodulators Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Autoimmune and Inflammatory Immunomodulators Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Autoimmune and Inflammatory Immunomodulators Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

以下、関連資料のご紹介

自己免疫治療薬の世界市場（～2026年）

Global Autoimmune Drugs Market Size, Status and Forecast 2020-2026
MRC2-11QY10931 2020年11月25日 93Pages
当調査資料は自己免疫治療薬のグローバル市場について調査・分析したレポートです。種類別（関節リウマチ（RA）、多発性硬化症（MS）、乾癬、炎症性腸疾患（IBD）、強直性脊椎炎（AS）、全身性エリテマトーデス（SLE））市場規模、用途別（病院、在宅医療、専門クリニック）市場規模、地域別（北米、米国、カナ...

炎症性腸疾患（IBD）治療の世界市場（～2026年）

Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12375 2020年11月25日 95Pages
当調査資料は炎症性腸疾患（IBD）治療のグローバル市場について調査・分析したレポートです。種類別（TNF阻害剤、アミノサリチル酸塩、免疫調節剤、コルチコステロイド）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

炎症性腸疾患（IBD）の世界市場（～2026年）

Global Inflammatory Bowel Disease Market Size, Status and Forecast 2020-2026
MRC2-11QY12376 2020年11月25日 98Pages
当調査資料は炎症性腸疾患（IBD）のグローバル市場について調査・分析したレポートです。種類別（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物学的薬剤）、免疫調節剤）市場規模、用途別（治療、診断）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

免疫調節剤の世界市場（～2026年）

Global Immunomodulators Market Insights and Forecast to 2026
MRC2-11QY01555 2020年11月20日 114Pages
当調査資料は免疫調節剤のグローバル市場について調査・分析したレポートです。種類別（免疫抑制剤、免疫賦活剤）市場規模、用途別（腫瘍学、呼吸器、HIV、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

動物用自己免疫疾患検査の世界市場（～2026年）

Global Animal Autoimmune Diseases Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY10847 2020年11月25日 92Pages
当調査資料は動物用自己免疫疾患検査のグローバル市場について調査・分析したレポートです。種類別（抗核抗体検査、クーム検査、エリテマトーデス細胞検査、免疫蛍光抗体検査、凝固検査、その他）市場規模、用途別（コンパニオンアニマル、家畜動物）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...

抗炎症ペプチドの世界市場（～2026年）

Global Anti-Inflammatory Peptides Market Insights and Forecast to 2026
MRC2-11QY02565 2020年11月20日 114Pages
当調査資料は抗炎症ペプチドのグローバル市場について調査・分析したレポートです。種類別（心血管疾患、胃腸疾患、皮膚疾患、神経疾患、耳鼻咽喉科疾患・眼科、呼吸器疾患・肺疾患、腎疾患、リウマチ・自己免疫疾患、移植）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨ...

自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年）

Global In Vitro Diagnostics (IVD) And Laboratory Developed Tests For Autoimmune Diseases Market Size, Status and Forecast 2020-2026
MRC2-11QY12322 2020年11月25日 90Pages
当調査資料は自己免疫疾患用体外診断（IVD）・ラボ開発検査のグローバル市場について調査・分析したレポートです。種類別（試薬・キット、機器、サービス、データ管理ソフトウェア）市場規模、用途別（糖尿病、感染症、腫瘍/癌、心臓病学、腎臓病学、自己免疫疾患、薬物検査、HIV/エイズ）市場規模、地域別（北米、...

自己免疫疾患診断の世界市場（～2026年）

Global Autoimmune Disease Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY10930 2020年11月25日 132Pages
当調査資料は自己免疫疾患診断のグローバル市場について調査・分析したレポートです。種類別（分析装置、アッセイキット）市場規模、用途別（病院、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾...

炎症性心疾患の世界市場（～2026年）

Global Inflammatory Heart Disease Market Size, Status and Forecast 2020-2026
MRC2-11QY12377 2020年11月25日 91Pages
当調査資料は炎症性心疾患のグローバル市場について調査・分析したレポートです。種類別（アテローム性動脈硬化症、心筋炎、心膜炎）市場規模、用途別（病院・診断センター、外来サービスセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

免疫介在性炎症性疾患治療の世界市場（～2026年）

Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12310 2020年11月25日 97Pages
当調査資料は免疫介在性炎症性疾患治療のグローバル市場について調査・分析したレポートです。種類別（標的化生物学的療法、新治療法）市場規模、用途別（病院、薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…
炎症性腸疾患（IBD）の世界市場（～2026年） Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stom…
免疫調節剤の世界市場（～2026年） Immunomodulators are referred to as the medications that are used for the regulation or for normalizing the immune system. The global market for immunomodualtors is expected to grow exponentially over the forecast period owing to the rising cases of chronic diseases such as multiple sclerosis, aller…
動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…